|Mr. Robert Maurice Powell Jr.||Chairman of the Management Board & CEO of Fresenius Medical Care Management AG||4.05M||N/A||1955|
|Ms. Helen Giza||Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Medical Care Mgmt AG||2.07M||N/A||1968|
|Mr. Kent Wanzek||CEO of Global Mfg, Quality & Supply and Member of Management Board - Fresenius Medical Care Mgmt AG||2.31M||N/A||1959|
|Dr. Franklin W. Maddux F.A.C.P.||Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG||1.85M||N/A||1957|
|Mr. Harry de Wit||CEO of Asia-Pacific Segment & Member of Management Board of Fresenius Medical Care Management AG||2.45M||N/A||1962|
|Mr. William Valle||CEO of North America Segment & Member of Management Board of Fresenius Medical Care Management AG||7.28M||N/A||1960|
|Dr. Katarzyna Mazur-Hofsab Ph.D.||CEO for EMEA Segment & Member of Management Board of Fresenius Medical Care Management AG||1.9M||N/A||1963|
|Dr. Olaf Schermeier||CEO of Global R&D||2.13M||N/A||1972|
|Ms. Rachel Clare Empey||Member of Supervisory Board of Fresenius Medical Care Management AG||77k||N/A||1976|
|Dr. Dominik Heger||Exec. VP and Head of Investor Relations, Strategic Devel. & Communications||N/A||N/A||N/A|
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co. KGaA’s ISS governance QualityScore as of 26 September 2021 is 8. The pillar scores are Audit: 10; Board: 6; Shareholder rights: 1; Compensation: 1.